This grant from the National Institutes of Health aims to support research on the potential of Myeloid-Derived Suppressor Cells (MDSCs) as therapeutic targets for tuberculosis in HIV co-infection. Researchers are encouraged to explore innovative clinical, preclinical, and non-clinical approaches to understand the role of MDSCs in host-directed therapeutics and Mycobacterium tuberculosis pathogenesis. Closing date for applications is January 10, 2022, 12:00:00 AM EST.
Opportunity ID: 320195
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-357 |
| Funding Opportunity Title: | Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 03, 2019 |
| Last Updated Date: | Sep 03, 2019 |
| Original Closing Date for Applications: | Jan 10, 2022 |
| Current Closing Date for Applications: | Jan 10, 2022 |
| Archive Date: | Feb 15, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Special district governments Native American tribal governments (Federally recognized) Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities State governments City or township governments County governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of innovative clinical, and preclinical and/non-clinical research to determine the potential of MDSCs as a target for host-directed therapeutics for tuberculosis in the context of HIV co-infection, and to better understand the role of host-induced immunosuppression in the progression of Mycobacterium tuberculosis pathogenesis. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-357.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259205 | Dec 06, 2019 | Jan 24, 2022 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00254502 | Dec 06, 2019 | May 24, 2020 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269708 | Oct 28, 2021 | Jan 10, 2022 | View |
Package 1
Mandatory forms
320195 RR_SF424_2_0-2.0.pdf
320195 PHS398_CoverPageSupplement_5_0-5.0.pdf
320195 RR_OtherProjectInfo_1_4-1.4.pdf
320195 PerformanceSite_2_0-2.0.pdf
320195 RR_KeyPersonExpanded_2_0-2.0.pdf
320195 PHS398_ResearchPlan_4_0-4.0.pdf
320195 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
320195 RR_Budget_1_4-1.4.pdf
320195 RR_SubawardBudget30_1_4-1.4.pdf
320195 PHS398_ModularBudget_1_2-1.2.pdf
320195 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
320195 RR_SF424_2_0-2.0.pdf
320195 PHS398_CoverPageSupplement_4_0-4.0.pdf
320195 RR_OtherProjectInfo_1_4-1.4.pdf
320195 PerformanceSite_2_0-2.0.pdf
320195 RR_KeyPersonExpanded_2_0-2.0.pdf
320195 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
320195 RR_Budget_1_4-1.4.pdf
320195 RR_SubawardBudget30_1_4-1.4.pdf
320195 PHS398_ModularBudget_1_2-1.2.pdf
320195 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
320195 RR_SF424_5_0-5.0.pdf
320195 PHS398_CoverPageSupplement_5_0-5.0.pdf
320195 RR_OtherProjectInfo_1_4-1.4.pdf
320195 PerformanceSite_4_0-4.0.pdf
320195 RR_KeyPersonExpanded_4_0-4.0.pdf
320195 PHS398_ResearchPlan_4_0-4.0.pdf
320195 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
320195 RR_Budget_3_0-3.0.pdf
320195 RR_SubawardBudget30_3_0-3.0.pdf
320195 PHS398_ModularBudget_1_2-1.2.pdf
320195 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
